Papers describe liquid biopsy next-generation sequencing

At least five recently published studies have shown the utility of liquid-based biopsies in cancer detection, suggesting that liquid biopsy next-generation sequencing (NGS) could replace traditional detection methods of PCR and tumor biopsies. In addition, a new approach using RNA from platelets that interact with tumors shows promise.

In a paper published in Cancer Cell, a team including researchers from VU University Medical Center utilized "swarm intelligence"

Read the full 662 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE